Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

NEWS

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
Tuesday, 3rd December at 8:38 am
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 4,064,040 shares of common stock, issued by the Company on August 22, 2024 (the "Existing Warrants"), at the exercise price of $1.00 per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to an effective registration statement on Form S-3 (File No. 333-281909). The closing of the offering is expected to occur on or about December 3, 2024, subject to satisfaction of customary closing conditions.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
8
Translate
Report
3125 Views
Comment
Sign in to post a comment